We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




3D Mammography Helps Detect Breast Cancer Earlier

By MedImaging International staff writers
Posted on 06 Mar 2016
Print article
A new study concludes that screening with digital breast tomosynthesis (DBT) combined with digital mammography (DM) increases breast cancer detection rates.

Researchers at the University of Pennsylvania (Philadelphia, USA) conducted a retrospective, four-year study of screening mammography metrics to determine if the improved outcomes observed after initial implementation of DBT screening are sustainable over time, and to evaluate the effect of more than one DBT screening at the individual level. In all, 44,468 screening events were performed on 23,958 unique women. The researchers then assessed the differences in outcomes between each DBT year and the DM year.

The researchers evaluated the results between groups of women with only 1, 2, or 3 DBT screenings, and also calculated the odds of recall adjusted for age, race and ethnicity, breast density, and prior mammograms. The results showed that the yearly rate of women called back for additional imaging decreased with the number of years they received three dimensional (3D) DBT mammography exams. Per 1,000 women, 130 were recalled in the first year of 3D mammography exams, 78 after two years, and only 59 after three years.

The analysis also showed that the yearly rate of women called back for additional imaging with 3D DBT mammography was consistently lower than the rate with standard 2D mammography. Concomitantly, the cancer detection rate per 1,000 women increased from 4.6 with 2D mammography to 5.5 in year one of 3D DBT mammography screenings, 5.8 in year two, and 6.1 in year three. Interval cancer rates decreased from 0.7% with the use of DM to 0.5% with the use of DBT. The study was published on February 18, 2016, in JAMA Oncology.

“We found that reduction in recall was sustainable at a population level, with additional reduction in recall as women returned for a second and third DBT examination,” concluded senior author Emily Conant, MD, and colleagues of the department of radiology and the computational breast imaging group. “These findings reaffirm that 3D mammography is a better mammogram for breast cancer screening […] and are an important step toward informing policies so that all women can receive 3D mammography for screening.”

DBT mammograms use low dose X-rays to create a 3D image of the breast, which can then be viewed in narrow slices, similarly to CT scan images. While in conventional 2D mammography overlapping tissues can mask suspicious areas, 3D images eliminate the overlap, making abnormalities easier to recognize. Experts estimate that 3D mammography will replace conventional mammography within ten years.

Related Links:

University of Pennsylvania


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
DR Flat Panel Detector
1500L
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Computed Tomography (CT) Scanner
Aquilion Serve SP

Print article

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.